Yuen AWC, Keezer MR, Sander JW (2018) Epilepsy is a neurological and a systemic disorder. Epilepsy Behav 78:57–61

Article  PubMed  Google Scholar 

Giourou E, Stavropoulou-Deli A, Giannakopoulou A, Kostopoulos GK, Koutroumanidis M (2015) In: Voros NS, Antonopoulos CP (eds) Cyberphysical systems for epilepsy and related brain disorders: multi-parametric monitoring and analysis for diagnosis and optimal disease management. Cham, Springer International Publishing., 11–38. https://doi.org/10.1007/978-3-319-20049-1_2. Accessed 2 May 2024

https://www.sciencedirect.com/science/article/abs/pii/S0920121115000030. Accessed 20 Oct 2024

Larsen LE, Caestecker S, Stevens L, van Mierlo P, Carrette E, Boon P, ..., Raedt R (2023) Hippocampal seizures differentially modulate locus coeruleus activity and result in consistent time-locked release of noradrenaline in rat hippocampus. Neurobiol Dis 189:106355

Wang P, Yin T, Ma HY, Liu DQ, Sheng YH, Wang C, Zhou BT (2015) Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Epilepsy Res 117:52–57

Article  CAS  PubMed  Google Scholar 

Abdel Ghaffar NF, Asiri RN, AL-Eitan LN, Alamri RS, Alshyarba RM, Alrefeidi FA, Asiri A, Alghamdi MA (2021) Improving public stigma, sociocultural beliefs, and social identity for people with epilepsy in the Aseer region of Saudi Arabia. Epilepsy Behav Rep 16:100442

Article  PubMed  PubMed Central  Google Scholar 

Moualek D, Pacha LA, Abrouk S, Kediha MI, Nouioua S, Aissa LA, Bellatache M, Belarbi S, Slimani S, Khennouf H et al (2012) Multicenter transversal two-phase study to determine a national prevalence of epilepsy in Algeria. Neuroepidemiology 39(2):131–134

Article  PubMed  Google Scholar 

https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/phar.1855. Accessed 21 Aug 2024

Goldenberg MM (2010) Overview of drugs used for epilepsy and seizures:etiology, diagnosis, and treatment. P T Peer-Rev J Formul Manag 35(7):392–415

Google Scholar 

Shahid A, Hameed K, Zainab A, Zafar A, Abbas S (2024) Advances in pharmacogenomics: optimizing antiepileptic drug therapy for drug-resistant epilepsy. Explor Neuroprotective Ther 4(3):240–250

Article  Google Scholar 

Sisodiya SM (2003) // Curr. Opin Neurol 16(2):197

Article  CAS  Google Scholar 

https://databases.lovd.nl/shared/genes/ABCB1. Accessed 29 Aug 2024

https://www.sciencedirect.com/science/article/abs/pii/0005273676901607. Accessed 29 Aug 2024

Boughrara W, Chentouf A (2022) The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review. Acta Neurol Belg 122(4):871–880

Article  PubMed  Google Scholar 

Tomson T, Zelano J, Dang YL, Perucca P (2023) The pharmacological treatment of epilepsy in adults. Epileptic Disorders 25(5):649–669

Article  PubMed  Google Scholar 

Riffi R, Boughrara W, Chentouf A, Ilias W, Taieb Ibrahim NM, Alioua Berrebbah A, Belhocine F (2024) CNS Neurol Disord Drug Targets. https://doi.org/10.2174/0118715273298953240529100325. Accessed 29 Aug 2024

Djordjevic N, Jankovic SM, Milovanovic JR (2017) Eur J Drug Metab Pharmacokinet 42(5):729–744

https://www.pnas.org/doi/abs/10.1073/pnas.97.7.3473. Accessed 29 Aug 2024

https://www.sciencedirect.com/science/article/abs/pii/S1357303916300433. Accessed 14 Jan 2025

https://www.nejm.org/doi/full/10.1056/nejmoa021986. Accessed 4 June 2024

Fisher RS (2017) CurrNeurol Neurosci Rep 17(6):48

https://www.nejm.org/doi/full/10.1056/NEJM200002033420503. Accessed 23 Aug 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904059/. Accessed 23 Aug 2024

https://www.tandfonline.com/doi/abs/10.1517/14622416.6.4.411. Accessed 23 Aug 2024

Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui ACF, Yu E, Wong LKS (2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 11(1):112–117

Article  PubMed  Google Scholar 

https://www.tandfonline.com/doi/abs/10.1080/17512433.2018.1486707. Accessed 29 Aug 2024

https://www.sciencedirect.com/topics/medicine-and-dentistry/enzyme-multiplied-immunoassay-technique. Accessed 27 Aug 2024

Raj Panday D, Panday KR, Basnet M, Kafle S, Shah B, Rauniar G (2017) Int J Neurorehabilitation 04(01). .https://www.omicsgroup.org/journals/therapeutic-drug-monitoring-of-carbamazepine-2376-0281-1000245.php?aid=85963. Accessed 29 Aug 2024

Tomson T, Tybring G, Bertilsson L, Ekbom K, Rane A (1980) Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch Neurol 37(11):699–703

Article  CAS  PubMed  Google Scholar 

Nasiri H, Forouzandeh M, Rasaee MJ, Rahbarizadeh F (2005) Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal 19(6):229–232

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang H-W, Cheng Y-H, Chuang L-Y, Yang C-H (2010) Confronting two-pair primer design for enzyme-free SNP genotyping based on a genetic algorithm. BMC Bioinformatics 11(1):173

Article  PubMed  PubMed Central  Google Scholar 

Zhang M-L, Chen X-L, Bai Z-F, Zhao X, Li W-X, Wang X-Y, Zhang H, Chen X-F, Zhang S-Q, Tang J-F et al (2021) ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. Gene 805:145907

Article  CAS  PubMed  Google Scholar 

Fan Y-X, Zhang Z, Meng J-R, Yin S-J, Wang P, Zhou T, Huang Y-H, Meng R, He G-H (2021) Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis. Epilepsy Res 177:106785

Article  CAS  PubMed  Google Scholar 

Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y (2011) // Epilepsy Behav. EB 21(1):27–30

Google Scholar 

Jaramillo NM, Galindo IF, Vázquez AO, Cook HJ, LLerena A, López ML (2014) Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. Drug Metabol. Drug Interact 29(2):67–79

Article  CAS  PubMed  Google Scholar 

Wang S-J, Zhao M-Y, Zhao P-C, Zhang W, Rao G-W (2024) // Curr. Med Chem 31(4):410–452

CAS  Google Scholar 

https://link.springer.com/article/10.1186/s41983-024-00859-z. Accessed 20 Oct 2024

https://journals.sagepub.com/doi/10.1177/1535759720905516. Accessed 12 Aug 2024

Gierbolini J, Giarratano M, Benbadis SR (2016) Carbamazepine-related antiepileptic drugs for the treatment of epilepsy-a comparative review. Expert Opin Pharmacother 17(7):885–888

Article  PubMed  Google Scholar 

Chentouf A, Dahdouh A, Guipponi M, Oubaiche ML, Chaouch M, Hamamy H, Antonarakis SE (2015) Familial epilepsy in Algeria: Clinical features and inheritance profiles. Seizure 31:2–18

Article  Google Scholar 

Kim DW, Kim M, Lee SK, Kang R, Lee S-Y (2006) Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure 15(5):344–347

Article  PubMed  Google Scholar 

Ozgon GO, Bebek N, Gul G, Cine N (2007) Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. Eur Neurol 59(1–2):67–70

PubMed  Google Scholar 

Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, ..., Liu ZQ (2012) ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neuroscience & Therapeutics 18(8):647–651

Zhu X, Yun W, Sun X, Qiu F, Zhao L, Guo Y (2014) Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in chinese patients with epilepsy. Pharmacogenomics 15(15):1867–1879

Article  CAS  PubMed  Google Scholar 

https://www.tandfonline.com/doi/abs/10.2217/14622416.7.4.551. Accessed 29 Aug 2024

Shaheen U, Prasad DKV, Sharma V, Suryaprabha T, Ahuja YR, Jyothy A, Munshi A (2014) Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy. Epilepsy Res 108(2):251–256

Article  CAS  PubMed  Google Scholar 

Chouchi M, Kaabachi W, Klaa H, Tizaoui K, Turki IB-Y , Hila L (2017) BMC Neurol 17(1):32

Al-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Aljamal HA (2019) Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients. Pharmacogenomics Pers Med 87–95

Al-Eitan LN, Al-Dalala IM, Elshammari AK, Khreisat WH, Nimiri AF, Alnaamneh AH, ..., Alghamdi MA (2020) Genetic association of epilepsy and anti-epileptic drugs treatment in jordanian patients. Pharmacogenomics Pers Med 503–510

AL-Eitan LN, Al-Dalalah IM, Aljamal HA (2019) Saudi Pharm J 27(5):731–737

AL-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Al-Quasmi MN, Aljamal HA (2019) Pharmacogenomics Pers Med 12:225–233

Chouchi M, Klaa H, Ben-Youssef Turki I, Hila L (2019) ABCB1 polymorphisms and drug-resistant epilepsy in a Tunisian population. Dis Markers 2019(1):1343650

Leschziner G, Jorgensen AL, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ, ..., Andrew T (2006) Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study. Lancet Neurol 5(8):668–676

Rashid HU, Ullah S, Carr DF, Khattak MIK, Asad MI, Rehman MU, Tipu MK (2024) MolBiol Rep 51(1):191

Taur SR, Kulkarni NB, Gandhe PP, Thelma BK, Ravat SH, Gogtay NJ, Thatte UM (2014) Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs. J Postgrad Med 60(3):265–269

Article  CAS  PubMed  Google Scholar 

Puranik YG, Birnbaum AK, Marino SE, Ahmed G, Cloyd JC, Remmel RP, Leppik IE, Lamba JK (2013) Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 14(1):35–45

Article  CAS  PubMed  Google Scholar 

Dhivya E, Kesavan R, Pradeep NP (2024) Drug Metab Pers Ther 39(1):27–34

Eichhorn A, Neumann F, Bäumler C, Gutsmann I, Grobe O, Schlüter F, Müller S, Krumbholz A (2024) Assessment of the diagnostic performance of fully automated hepatitis E virus (HEV) antibody tests. Diagnostics 14(6):602

Article  CAS